Erratum to: Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)

Gascón, Pere; Aapro, Matti; Ludwig, Heinz; Bokemeyer, Carsten; Boccadoro, Mario; Turner, Matthew; Denhaerynck, Kris; MacDonald, Karen; Abraham, Ivo

doi:10.1007/s00520-015-2991-3

Erratum to: Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)

Erratum
Published: 19 October 2015

Volume 24, page 927, (2016)
Cite this article

Download PDF

Supportive Care in Cancer Aims and scope Submit manuscript

Erratum to: Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)

Download PDF

Pere Gascón¹,
Matti Aapro²,
Heinz Ludwig³,
Carsten Bokemeyer⁴,
Mario Boccadoro⁵,
Matthew Turner⁶,
Kris Denhaerynck⁷,
Karen MacDonald⁷ &
…
Ivo Abraham^7,8

1764 Accesses
Explore all metrics

The Original Article was published on 27 August 2015

Erratum to: Support Care Cancer

DOI 10.1007/s00520-015-2861-z

Table 1 footer definition for “advanced disease” (footer d) should read: d Stage 4 (Stage 3 if multiple myeloma) and prior chemo in metastatic setting

Author information

Authors and Affiliations

Division of Medical Oncology, Department of Hematology-Oncology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain
Pere Gascón
Institut Multidisciplinaire d’Oncologie, Clinique de Genolier, Genolier, Switzerland
Matti Aapro
Medizinische Abteilung I–Onkologie und Haematologie, Wilhelminenspital, Wien, Austria
Heinz Ludwig
Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany
Carsten Bokemeyer
Dipartimento di Oncologia e Ematologia, Azienda Ospedaliero, Universitaria S. Giovanni Battista di Torino, Torino, Italy
Mario Boccadoro
Sandoz Biopharmaceuticals, Holzkirchen, Germany
Matthew Turner
Matrix45, Tucson, AZ, USA
Kris Denhaerynck, Karen MacDonald & Ivo Abraham
Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Drachman Hall B306H, 1295 N Martin, Tucson, AZ, 85721, USA
Ivo Abraham

Authors

Pere Gascón
View author publications
You can also search for this author in PubMed Google Scholar
Matti Aapro
View author publications
You can also search for this author in PubMed Google Scholar
Heinz Ludwig
View author publications
You can also search for this author in PubMed Google Scholar
Carsten Bokemeyer
View author publications
You can also search for this author in PubMed Google Scholar
Mario Boccadoro
View author publications
You can also search for this author in PubMed Google Scholar
Matthew Turner
View author publications
You can also search for this author in PubMed Google Scholar
Kris Denhaerynck
View author publications
You can also search for this author in PubMed Google Scholar
Karen MacDonald
View author publications
You can also search for this author in PubMed Google Scholar
Ivo Abraham
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ivo Abraham.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gascón, P., Aapro, M., Ludwig, H. et al. Erratum to: Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study). Support Care Cancer 24, 927 (2016). https://doi.org/10.1007/s00520-015-2991-3

Download citation

Published: 19 October 2015
Issue Date: February 2016
DOI: https://doi.org/10.1007/s00520-015-2991-3

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Erratum to: Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)

Author information

Authors and Affiliations

Corresponding author

Rights and permissions

About this article

Cite this article

Share this article

Search

Navigation